Healthcare News and Research

Latest Healthcare News and Research

Eli Lilly to discontinue development of tabalumab due to insufficient efficacy in Phase 3 Lupus trials

Eli Lilly and Company announced today it will discontinue development of tabalumab -- being studied for the treatment of systemic lupus erythematosus (SLE, commonly known as lupus) -- due to insufficient efficacy in two pivotal Phase 3 trials. The decision was not based on safety concerns.

3 Oct 2014

Financial ties between doctors and health firms explored

Federal data shows that doctors and other health care professionals made more than $212 million in speaking and consulting for drug and device makers in the five months at the end of last year, reports The New York Times.

3 Oct 2014

Supreme Court to hear Idaho Medicaid rate case

The case centers on whether private health care providers can force the state to raise its Medicaid rates because of the rising cost of services.

3 Oct 2014

CytoSorbents announces launch of International CytoSorb Treatment Registry

CytoSorbents Corporation, a critical care immunotherapy company using blood purification to treat life-threatening conditions, announced the launch of its International CytoSorb Treatment Registry, established and managed by the Center of Clinical Trials at the University of Jena, Germany.

3 Oct 2014

BioCap conference showcased life sciences companies in the North

The unique BioCap conference organised by Bionow, a not for profit membership organisation for the biomedical / life-sciences industry, was a great success, combining the forces of science and financial investment enabling businesses from all over the North to secure essential funding.

3 Oct 2014

Viewpoints: Another troubled website rollout; insurers fight consumer measures in Calif.

If the federal government's new Open Payments website were a consumer product, it would be returned to the manufacturer for a full refund. Open Payments is the government's site for publishing payments made to doctors and teaching hospitals by drug and medical device manufacturers. It includes 4.4 million payments, worth $3.5 billion, to more than half a million doctors and almost 1,360 teaching hospitals (Charles Ornstein, 10/1).

3 Oct 2014

Humalog 200 units/ml KwikPen insulin gets marketing approval in EU for treatment of diabetes

Eli Lilly and Company today announced that the European Commission has granted marketing authorisation for Humalog 200 units/ml KwikPen (insulin lispro 200 units/ml) for the treatment of diabetes in adults.

3 Oct 2014

State highlights: Infant mortality rises in D.C.; Medicaid managed care rates

The District's infant mortality rate ticked up in 2012, city officials announced Wednesday -- an unwelcome development that comes amid the loss of a key federal grant and the launch of a new effort to reduce infant deaths (DeBonis, 10/1).

3 Oct 2014

Large number of Canadian stroke patients not getting help to get back to active life

Too many stroke patients in Canada are not getting the rehabilitation they need to return to a healthy, active life, according to a new study which will be presented at the Canadian Stroke Congress in Vancouver tomorrow.

3 Oct 2014

Lucideon announces successful development of bioceramics for bone repair

As a partner in the EU-funded Bio-Bone project (Bioceramics for Bone Repair) Lucideon is pleased to announce that the pan-European consortium has successfully developed phosphate-glasses (p-glasses) with biomaterial properties for bone repair.

From Lucideon 3 Oct 2014

Pentagon targets poorly performing military hospitals, clinics

After a review found wide disparities in the quality of care provided by military-run hospitals and clinics, Defense Secretary Chuck Hagel ordered improvement plans for under-performing facilities. Some parts of the system performed better than in civilian-run ones, but treatment fells short in others.

3 Oct 2014

MSU to provide specialized health benefits to veterans

Mississippi State University will be the first higher learning institution in the nation to partner with the U.S. Department of Veterans Affairs to provide timely, specialized health benefits to veterans.

3 Oct 2014

Women survivors of sexual abuse may suffer emotional distress during pelvic examination

Women who have a history of violent sexual abuse may suffer emotional distress during a routine pelvic examination. Healthcare providers would benefit from greater awareness of symptoms predictive of examination-related distress in this patient population, according to a study published in Violence and Gender, a new peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

3 Oct 2014

BIDMC receives $20 million grant to evaluate, test monoclonal antibodies for HIV treatment

Beth Israel Deaconess Medical Center has received a four-year, $20 million grant from the Bill & Melinda Gates Foundation to evaluate and test broadly neutralizing monoclonal antibodies for the treatment of HIV.

3 Oct 2014

Parent coaching intervention benefits preschool-aged children with autism

A parent coaching intervention brings meaningful benefits for preschool-aged children with autism-spectrum disorders (ASD), according to a clinical trial in the October Journal of Developmental & Behavioral Pediatrics, the official journal of the Society for Developmental and Behavioral Pediatrics.

3 Oct 2014

Health exchange's one-year mark: Looking forward, looking back

As of Oct. 1, the health law's online marketplaces have been up and running for a year. News outlets offer status reports on what appears to have gone well, what problems remain as the second open enrollment period approaches and how these factors are playing politically.

3 Oct 2014

Healthcare News and Research

Latest Healthcare News and Research

Eli Lilly to discontinue development of tabalumab due to insufficient efficacy in Phase 3 Lupus trials

Financial ties between doctors and health firms explored

Supreme Court to hear Idaho Medicaid rate case

CytoSorbents announces launch of International CytoSorb Treatment Registry

BioCap conference showcased life sciences companies in the North

Viewpoints: Another troubled website rollout; insurers fight consumer measures in Calif.

Humalog 200 units/ml KwikPen insulin gets marketing approval in EU for treatment of diabetes

State highlights: Infant mortality rises in D.C.; Medicaid managed care rates

Large number of Canadian stroke patients not getting help to get back to active life

Lucideon announces successful development of bioceramics for bone repair

Pentagon targets poorly performing military hospitals, clinics

MSU to provide specialized health benefits to veterans

Women survivors of sexual abuse may suffer emotional distress during pelvic examination

BIDMC receives $20 million grant to evaluate, test monoclonal antibodies for HIV treatment

Parent coaching intervention benefits preschool-aged children with autism

Health exchange's one-year mark: Looking forward, looking back

Cepheid to acquire LABSCO's customer relationships for $21M

Family physician answers questions related to Ebola virus

University of Michigan, Biomed Central to publish new journal, Clinical Diabetes and Endocrinology

Open payments database debuts, detailing financial connections between physicians and drug makers

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in